FTC sues main pharmacy reward supervisors over insulin selling prices The company brought motion towards Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the checklist price of life-saving insulin medication. Earlier this summer months, the firm held prolonged negotiations with Steward more than https://daves-hot-chicken-nutriti74073.bloginder.com/31257449/not-known-details-about-healthcare-news